These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24513178)

  • 1. MiRNA in melanoma-derived exosomes.
    Gajos-Michniewicz A; Duechler M; Czyz M
    Cancer Lett; 2014 May; 347(1):29-37. PubMed ID: 24513178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum exosome isolation methods for microRNA profiling.
    Rekker K; Saare M; Roost AM; Kubo AL; Zarovni N; Chiesi A; Salumets A; Peters M
    Clin Biochem; 2014 Jan; 47(1-2):135-8. PubMed ID: 24183884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
    Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.
    Zhao L; Liu W; Xiao J; Cao B
    Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the miRNA Profiles of Melanoma Exosomes Derived Under Normoxic and Hypoxic Culture Conditions.
    Wozniak M; Peczek L; Czernek L; Düchler M
    Anticancer Res; 2017 Dec; 37(12):6779-6789. PubMed ID: 29187456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
    Xiao D; Ohlendorf J; Chen Y; Taylor DD; Rai SN; Waigel S; Zacharias W; Hao H; McMasters KM
    PLoS One; 2012; 7(10):e46874. PubMed ID: 23056502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome isolation for proteomic analyses and RNA profiling.
    Taylor DD; Zacharias W; Gercel-Taylor C
    Methods Mol Biol; 2011; 728():235-46. PubMed ID: 21468952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
    Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
    Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ single step detection of exosome microRNA using molecular beacon.
    Lee JH; Kim JA; Kwon MH; Kang JY; Rhee WJ
    Biomaterials; 2015 Jun; 54():116-25. PubMed ID: 25907045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
    Van Giau V; An SS
    J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous and multiplexed detection of exosome microRNAs using molecular beacons.
    Lee JH; Kim JA; Jeong S; Rhee WJ
    Biosens Bioelectron; 2016 Dec; 86():202-210. PubMed ID: 27372573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respiration.
    Bland CL; Byrne-Hoffman CN; Fernandez A; Rellick SL; Deng W; Klinke DJ
    FEBS J; 2018 Mar; 285(6):1033-1050. PubMed ID: 29399967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.
    Hood JL; San RS; Wickline SA
    Cancer Res; 2011 Jun; 71(11):3792-801. PubMed ID: 21478294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment.
    Kosaka N; Takeshita F; Yoshioka Y; Hagiwara K; Katsuda T; Ono M; Ochiya T
    Adv Drug Deliv Rev; 2013 Mar; 65(3):376-82. PubMed ID: 22841506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment.
    Ye Q; Li Z; Li Y; Li Y; Zhang Y; Gui R; Cui Y; Zhang Q; Qian L; Xiong Y; Yu Y
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.
    Vignard V; Labbé M; Marec N; André-Grégoire G; Jouand N; Fonteneau JF; Labarrière N; Fradin D
    Cancer Immunol Res; 2020 Feb; 8(2):255-267. PubMed ID: 31857348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP; Kerin MJ; Dwyer RM
    Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum exosomal microRNAs as potent circulating biomarkers for melanoma.
    Tengda L; Shuping L; Mingli G; Jie G; Yun L; Weiwei Z; Anmei D
    Melanoma Res; 2018 Aug; 28(4):295-303. PubMed ID: 29750752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.